Breaking News Instant updates and real-time market news.

CFRX

ContraFect

$2.23

0.0834 (3.88%)

06:09
11/21/16
11/21
06:09
11/21/16
06:09

ContraFect price target raised to $4.50 from $3.50 at Piper Jaffray

Piper Jaffray analyst Edward Tenthoff raised his price target for ContraFect to $4.50 after attending the inaugural Lysin Meeting at Rockefeller University. The analyst was impressed by the "significant fundamental biological progress" and broad potential applicability of lysins as a novel class of antibiotics. He reiterates an Overweight rating on ContraFect.

  • 29

    Nov

CFRX ContraFect
$2.23

0.0834 (3.88%)

05/10/16
ROTH
05/10/16
DOWNGRADE
ROTH
Neutral
ContraFect downgraded to Neutral from Buy at Roth Capital
07/28/16
PIPR
07/28/16
INITIATION
Target $3.5
PIPR
Overweight
ContraFect initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff started ContraFect with an Overweight rating and $3.50 price target.
09/28/16
WBLR
09/28/16
INITIATION
Target $7
WBLR
Outperform
ContraFect initiated with an Outperform at William Blair
William Blair analyst Y. Katherine Xu started ContraFect with an Outperform rating.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.